Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 501,983 | 422,000 | 418,957 | 437,108 | 402,833 |
| Income taxes - deferred | 3,060 | N/A | -9,295 | 80,087 | 23,986 |
| Accounts receivable | -20,035 | 177,000 | -250,495 | -73,318 | 118,676 |
| Accounts payable and accrued liabilities | 59,297 | N/A | -214,885 | -225,385 | -63,953 |
| Other Working Capital | 75,479 | 123,000 | -407,699 | -133,408 | 33,664 |
| Other Operating Activity | 37,826 | 29,000 | 622,114 | 583,963 | 176,475 |
| Operating Cash Flow | $657,610 | $751,000 | $158,697 | $669,047 | $691,681 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -156,656 | -169,000 | -159,854 | -268,702 | -181,060 |
| Net Acquisitions | 37,502 | N/A | -22,266 | -113,712 | -141,189 |
| Purchase Of Investment | -6,324 | N/A | -42,665 | -66,441 | -323 |
| Sale Of Investment | 24,686 | N/A | 13,469 | 26,065 | 22,312 |
| Other Investing Activity | 0 | -169,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-100,792 | $-338,000 | $-211,316 | $-422,790 | $-300,260 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -836,924 | N/A | -144,080 | -105,278 | -20,493 |
| Debt Issued | 801,843 | N/A | 753,564 | 12,338 | 1,650 |
| Debt Repayment | -241,371 | N/A | -820,926 | -194,560 | -195,339 |
| Other Financing Activity | -226,080 | 0 | -55,199 | -70,033 | -74,348 |
| Financing Cash Flow | $-502,532 | $N/A | $-266,641 | $-357,533 | $-288,530 |
| Exchange Rate Effect | 34,594 | N/A | 10,947 | 31,097 | 50,985 |
| Beginning Cash Position | 1,024,672 | N/A | 1,481,655 | 1,561,834 | 1,407,958 |
| End Cash Position | 1,113,552 | N/A | 1,173,342 | 1,481,655 | 1,561,834 |
| Net Cash Flow | $54,286 | $N/A | $-319,260 | $-111,276 | $102,891 |
| Free Cash Flow | |||||
| Operating Cash Flow | 657,610 | 751,000 | 158,697 | 669,047 | 691,681 |
| Capital Expenditure | -160,337 | -341,000 | -162,086 | -266,162 | -194,540 |
| Free Cash Flow | 497,273 | 410,000 | -3,389 | 402,885 | 497,141 |